Association of health-related quality of life with dual use of prescription and over-the-counter nonsteroidal antiinflammatory drugs

Arthritis Care and Research

Volumn 59, Issue 2, 2008, Pages 227-233

  Kovac, Stacey H ^a,c   Saag, Kenneth G ^b   Curtis, Jeffrey R ^b   Allison, Jeroan ^b  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANALGESIA; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL RECORD; MUSCULOSKELETAL PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY OF LIFE; RISK ASSESSMENT; SYMPTOM; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; DRUGS, NON-PRESCRIPTION; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCULOSKELETAL DISEASES; PAIN; PRESCRIPTIONS, DRUG; QUALITY OF LIFE;

EID: 39449092435     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23336     Document Type: Article

References (33)

1. CDC. Prevalence of self-reported arthritis or chronic joint symptoms among adults: United States, 2001. MMWR 2002;51:948-50.
2. CDC. Prevalence and impact of arthritis by race and ethnicity: United States, 1989-1991. MMWR 1996;45:373-8.
3. Roth SH. Non-steroidal anti-inflammatory drugs: gastropathy, deaths and medical practice [editorial]. Ann Intern Med 1988;109:353-4.
4. Paulose-Ram R, Hirsch R, Dillon C, Gu Q. Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among US adults. Pharmacoepidemiol Drug Saf 2005;14:257-66.
5. Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public, perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol 2005;32:2218-24.
6. CDC. Prevalence of disabilities and associated health conditions among adults: United States. 1999. MMWR 2001;50:120-5.
7. Bradley C, Blenkinsopp A. Over the counter drugs: the future for self medication. BMJ 1996;312:835-7.
8. Turunen JH, Mantyselka PT, Kumpusalo EA, Ahonen RS. Frequent analgesic use at population level: prevalence and patterns of use. Pain 2005;115:374-81.
9. Sleath B, Rubin RH, Campbell W, Gwyther L, Clark T. Physician-patient communication about over-the-counter medications. Soc Sci Med 2001;53:357-69.
10. Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs [published erratum appears in Lancet 1994;343:1302]. Lancet 1994;343:1075-8.
11. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
12. Rodriguez LA, Hernandez-Diaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res 2001;3:98-101.
13. Curtis JR, Olivieri J, Allison JJ, Gaffo A, Juarez L, Kovac SH, et al. A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugs. Am J Manag Care 2005;11:537-43.
14. CDC. Behavioral Risk Factor Surveillance System: operational and user's guide, version 3.0 URL: http://www.cdc.gov/brfss/pdf/userguide.pdf.
15. Ware JE, Keller SD. SF-12: how to score the SF-12 physical and mental health summary scales. Lincoln (RI): Quality Metric Incorporated and Health Assessment Lab: 2002.
16. Heckman J. The common structure of statistical models of truncation, sample selection, and limited dependent variables and a simple estimator for such models. Ann Econ Soc Meas 1976;5:457-92.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
18. Gandhi SK, Salmon JW, Zhao SZ, Lambert BL, Gore PR, Conrad K. Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials. Clin Ther 2001;23:1080-98.
19. Wilcox CM, Shalek KA, Cotsonis G. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Intern Med 1994;154:42-6.
20. Griffin MR, Scheiman JM. Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity. Am J Med 2001;110:33S-7S.
21. Straus WL, Ofman JJ. Gastrointestinal toxicity associated with nonsteroidal anti-inflammatory drugs: epidemiologic and economic issues. Gastroenterol Clin North Am 2001;30:895-920.
22. Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ. Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf 2002;11:687-93.
23. Panlose-Ram R, Hirsch R, Dillon C, Losonezy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf 2003;12:315-26.
24. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-44.
25. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
26. The Joint Commission. 2007 national patient safety goals ambulatory health care version manual chapter, including implementation expectations. 2007. URL: http://www.jointcommission.org/NR/rdonlyres/44D4E740-7385-4666-B9E4- 9EA7F769FB43/0/07 ahc_npsgs.pdf.
27. Parker JC, Smarr KL, Slaughter JR, Johnston SK, Priesmeyer ML, Hanson KD, et al. Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach. Arthritis Rheum 2003;49:766-77.
28. Pallant JF, Bailey CM. Assessment of the structure of the Hospital Anxiety and Depression Scale in musculoskeletal patients. Health Qual Life Outcomes 2005;3:82.
29. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
30. Shipton EA, Tait B. Flagging the pain: preventing the burden of chronic pain by identifying and treating risk factors in acute pain. Eur J Anaesthesiol 2005;22:405-12.
31. Gordon DB, Dahl JL, Miaskowski G, McCarberg B, Todd KH, Paice JA, et al. American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern Med 2005;165:1574-80.
32. Gureje O, Simon GE, Von Korff M. A cross-national study of the course of persistent pain in primary care. Pain 2001;92:195-200.
33. American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. JAMA 1995;274:1874-80.